Tian et al. (2020) [36] further found that the expression of ANP32a is increased in hepatocellular carcinoma patients, since ANP32a promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through the HMGA1/STAT3 pathway. Here, STAT3 is linked to hepatocellular carcinoma.